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Abstract: Inorganic–organic hybrid materials designed to facilitate bone tissue regeneration
use a calcium phosphate mineral layer to encourage cell adhesion, proliferation, and
osteogenic differentiation. Mineral formed on porous materials is often discontinuous through
the thickness of the scaffold. This study aimed to uniformly coat the pores of three-dimensional
(3D) porous, polymer scaffolds with a bone-like mineral layer in addition to uniformly
incorporating a model protein within this mineral layer. A filtration system designed to induce
simulated body fluid flow through the interstices of 3D polylactic-co-glycolic acid scaffolds (10-
mm diameter 3 2-mm thickness) illustrated that a uniform, continuous mineral layer can be
precipitated on the pore surfaces of a 3D porous structure within 5 days. MicroCT analysis
showed increased mineral volume percent (MV%) (7.86 6 3.25 MV%, p ¼ 0.029) and
continuous mineralization of filtered scaffolds compared with two static control groups
(floating, 0.166 0.26 MV% and submerged, 0.20 6 0.01 MV%). Furthermore, the system was
effective in coprecipitating a model protein, bone sialoprotein (BSA), within the mineral layer.
A 10-fold increase in BSA incorporation was seen when coprecipitated filtered scaffolds (1308
6 464 lg) were compared to a submerged static control group (139 6 45 lg), p < 0.001.
Confocal microscopy visually confirmed uniform coprecipitation of BSA throughout the
thickness of the filtration scaffolds. The designed system enables 3D mineralization through
the thickness of porous materials, and provides the option of including coprecipitated
biomolecular cues within the mineral layer. This approach of providing a 3D conductive and
osteoinductive environment could be conducive to bone tissue regeneration. ' 2007 Wiley
Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 84B: 340–349, 2008
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biomineralization
INTRODUCTION
The restoration and repair of orofacial and long-bone
defects resulting from disease, trauma, or genetic inheri-
tance is still a major clinical challenge.1–4 Autogenous
bone grafting is a current method used in repairing skeletal
defects. However, limitations including donor site morbid-
ity, graft rejection, and inadequate bone formation or qual-
ity often result.2,5 Current approaches in bone tissue
engineering strive to overcome these limitations and induce
bone formation using a combination of an extracellular ma-
trix analogue, cells, and/or biological signals.6–9
Three approaches are used in tissue engineering: con-
duction, induction, and cell transplantation.10,11 Initial
research has focused on a conductive approach that aims to
recruit host cells towards an implanted material and initiate
bone ingrowth or regeneration. Research using inductive
approaches of incorporating cell-recruiting or cell-directing
molecules in or on the implant has increased to improve
the rate, amount, and quality of bone being regenerated.12
In parallel, control of the location and direction of bone
growth via transplantation of bone cell lines, genetically
manipulated cells, or stem cells on these constructs has
been explored.13 Cells are typically seeded on highly po-
rous (>90%) scaffolds fabricated from biodegradable mate-
rials. To control cell responses, such as adhesion, the
material can be modified via surface alterations or coatings.
Specific to bone scaffolding, strategies to increase the
quantity and quality of regenerated bone include using or-
ganic/inorganic hybrid materials that promote bone healing
and remodeling. For example, the technique of biomimetically
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precipitating a bone-like mineral layer onto porous polymer
scaffolding provides cells a calcium phosphate material sur-
face that is chemically similar to the composition of natural
bone. This technique of biomimetically precipitating apatite
onto the surface of a biomaterial was first researched on
silica-rich Bioglass114 and was subsequently introduced on
titanium hip implants to enhance implant–bone osseointe-
gration.15 Biomimetic deposition of bone-like mineral
occurs at biological temperatures, making it an attractive
alternative to high-temperature processing methods such as
plasma spray and sputtering techniques.16,17 The biomi-
metic technique in bone tissue engineering has evolved into
mineralizing biodegradable polymeric scaffolds with the
intent of tailoring calcium phosphate ratios to evoke partic-
ular cell behavior while also increasing scaffold mechanical
integrity.18 The presence of bone-like mineral is hypothe-
sized to recruit host cells as well as to have the ability to
control the differentiation of transplanted cells towards a
bone phenotype.19
Surface pretreatments that create negatively charged sur-
face groups to accelerate mineral nucleation benefit both
2D and 3D materials. While growth of bone-like mineral
on polylactic-co-glycolic acid (PLGA) is attainable when a
premineralization hydrolysis20 or aminolysis21 treatment is
used, the apatite precipitated on 3D PLGA scaffolds is of-
ten discontinuous and can take up to 16 days to form.18,22
The lack of mineral continuity in 3D exists for both materi-
als that do and do not receive surface pretreatments, sup-
porting the need for innovations to improve current
processing techniques. The design goals of using second-
generation biomimetically mineralized materials therefore
aim to reduce the time of apatite formation and to uni-
formly mineralize the interstices of 3D scaffolding, while
controlling calcium phosphate ratios.23 To clarify terminol-
ogy used, a dense substrate amenable to mineralization,
such as a polymer or titanium surface is considered a 2D
surface; however, when the substrate becomes porous and
mineralization can occur through its thickness, the result is
a 3D structure or scaffold.
In addition to a bone-like mineral layer providing a
more conductive surface, the incorporation of inductive
agents such as proteins or growth factors into the mineral
can expose cells to spatiotemporally controlled biomolecu-
lar cues that can further promote and direct osteogenesis.
Methods of incorporating proteins include covalent attach-
ment, adsorption, and entrapment and are less than ideal
for sustained release. A promising alternative to these
methods is the coprecipitation of proteins and bone-like
mineral. Depositing a protein–mineral layer on a porous
scaffold provides a system that can deliver protein while
allowing tissue ingrowth in 3D. Another advantage to
coprecipitation is the ability to deposit bone-like mineral
and proteins at physiological temperatures, minimizing
potential processing parameters that could alter the biologi-
cal activity of the incorporated biomolecules.24–26 A third
advantage to coprecipitation is the ability to incorporate
different biomolecules at different stages of mineral deposi-
tion, which provides a means of controlling release
kinetics.19,27 Coprecipitation also leads to more sustained
biomolecule release compared to adsorption, increases
potential loading capacity, and is able to be used in con-
junction with adsorption to further control biomolecular
release.19,28 While coprecipitation is an effective means of
incorporating biomolecules in bone-like mineral on dense,
permanent implants, to be effective in tissue regeneration
there is a need to rapidly and uniformly coat pores through
the thickness of 3D scaffolding.
To study the effects of surface mineralization and bio-
molecular incorporation on bone growth in three dimen-
sions, a scaffold uniformly and continuously coated with
bone-like mineral or bone-like mineral with protein is nec-
essary. Therefore, a filtration system was designed to
induce flow of simulated body fluid (SBF), an ionic solu-
tion with similar ion concentrations as body serum, through
the pores of polymer scaffolding to achieve mineralization
throughout the thickness within 5 days. The goals of this
study were to demonstrate: (1) the filtration system is capa-
ble of coating the pores of a 3D scaffold with a uniform,
continuous bone-like mineral layer and (2) a model biomo-
lecule, BSA, is capable of being incorporated throughout
the 3D mineral layer. The hypothesis that flow of SBF
through porous scaffolding will initiate mineralization
within the pores of 3D scaffolds and induce the formation
of a uniform mineral layer in 3D is tested. Furthermore,
the capability of precipitating a continuous mineral–protein
layer in 3D is also investigated. A combination of micro-
computed tomography (MicroCT), X-ray diffraction
(XRD), protein quantification, and confocal microscopy is
used to illustrate uniform, continuous mineralization and




The scaffolds were fabricated using a salt-leaching method.
NaCl was sieved to 425–600 mm in diameter and packed
into 10-mm diameter wells in a Delrin1 (filtration group)
or Teflon1 (control groups) mold. A 5 wt % 85:15 PLGA
(i.v. ¼ 0.73 dL/g, Alkermes)–chloroform solution was
added to each well. The scaffolds were covered with alumi-
num foil and dried under a chemical fume hood for at least
36 h. The mold was then placed in distilled water (dH2O)
to leach out the salt particles for at least 36 h. The scaf-
folds were treated with 0.5M NaOH for 7 min and rinsed
with dH2O. The final thickness of the scaffolds was
approximately 2-mm.
SBF Preparation
Chemicals for making SBF were purchased from Sigma-
Aldrich unless otherwise noted. The chemicals and concen-
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trations used to make 13 SBF include 141 mM NaCl, 4.0
mM KCl, 0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM
NaHCO3, 5.0 mM CaCl22H2O, and 2.0 mM KH2PO4.29 To
prepare 23 and 43 SBF, the concentrations were doubled
and quadrupled, respectively. All SBF solutions were pre-
pared at 258C using dH2O. The 23 SBF was titrated to pH
6.8, and the 43 SBF was titrated to pH 6.4 using 1M
NaOH. These pH values were used to avoid homogenous
precipitation. Both 23 and 43 SBF were buffered with
Tris–HCl. All SBF solutions were filtered using a 0.22-mm
filter prior to use, and 0.005% sodium azide was added to
prevent bacterial contamination.
Mineralization of Scaffolds in the Filtration System
The Delrin1 mold with salt-leached scaffolds (n ¼ 4) was
attached to the actuator of an Instron 8521 servohydraulic
system and lowered into the aluminum base housing the
SBF (Figure 1). The filtration system base is filled with
SBF such that the scaffolds within the Delrin1 mold are
submerged with all surfaces being exposed to the SBF
throughout the experiment. SBF solutions were warmed to
378C prior to adding to the base. Initially, 1 L of 43 SBF
(pH ¼ 6.4) was used for 12 h, being replenished with fresh
solution after 6 h. Subsequently, 1 L of 23 SBF (pH ¼
6.8) replaced the 43 SBF and was replenished every 12 h.
The SBF was changed to sustain the appropriate ion con-
centration levels in addition to maintaining the pH of 6.4
or 6.8, which is conducive to heterogeneous precipitation
of bone like mineral onto the scaffolds. The pH values of
new (fresh SBF) and used (SBF being replenished) SBF
were measured using a pH meter (Mettler Toledo MP230).
A fatigue regimen was programmed on the Instron 8521 to
cycle the mold with the scaffolds at an amplitude of 25.4
mm at 0.011 Hz for 5 days. A temperature controller
(Extech Instruments, Model 48VTR) maintained a solution
temperature of 37 6 18C. Two static control groups, sub-
merged control (n ¼ 4) and floating control (n ¼ 4), were
subjected to the same SBF regimen (0.5 L SBF instead of
1 L) in a 378C incubator for 5 days. The submerged group
scaffolds were prepared in a Teflon1 mold. The scaffolds
in the floating static group were cast in a Teflon1 mold,
removed, and mineralized in 50-mL conical tubes contain-
ing 50 mL of SBF. The 5-day mineralization experiment
was repeated twice for all of the groups.
BSA Coprecipitation
The Delrin1 mold with salt-leached scaffolds (n ¼ 8) was
attached to the Instron 8521 system and lowered into the
aluminum base housing the SBF or SBF:FITC–BSA. Fluo-
roisothiocyanate (FITC) conjugated BSA (Sigma-Aldrich,
A9771) and BSA (Sigma-Aldrich, A3294) were used to
prepare SBF:FITC–BSA solutions with a 1:5 ratio of
FITC–BSA to BSA for a total protein concentration of 200
mg/mL. The SBF for these solutions was filtered using a
0.22-mm filter prior to the addition of FITC–BSA or BSA.
Initially, 1 L of 43 SBF (pH ¼ 6.4) was used for 12 h,
being replenished with fresh solution after 6 h. Subse-
quently, 1 L of 23 SBF:FITC–BSA (pH ¼ 6.8) replaced
the 43 SBF and was replenished every 12 h. The
SBF:FITC–BSA was changed to sustain the appropriate ion
concentration levels, to replenish the FITC–BSA supply,
and to maintain a pH of 6.8. A fatigue regimen was pro-
grammed on the Instron 8521 to cycle the mold with the
scaffolds at an amplitude of 25.4 mm at 0.011 Hz for a
total of 3 days. The temperature controller maintained a so-
lution temperature of 37 6 18C. A submerged static group
(n ¼ 8) was prepared in a Teflon1 mold and subjected to
the same SBF and SBF:FITC–BSA regimen in a 378C in-
cubator for 3 days. The floating control group was excluded
from this experiment, because the MicroCT analysis for
this group showed the least amount of mineral volume per-
cent (MV%) in the previously described 5 day mineraliza-
tion experiment. An equal volume of SBF was used for the
control and experimental groups to maintain similar FITC–
BSA concentrations. The coprecipitation experiment was
repeated twice for both groups.
MicroCT Analysis of Mineralized Scaffolds
After 5 or 3 days of mineralization, all scaffolds were
removed, rinsed in dH2O, and dried under a chemical fume
Figure 1. Schematic showing the filtration device. The device con-
sists of a Delrin1 mold (A), aluminum base (B), thermocouple (C),
temperature controller (D), and heating element (E). The Delrin1
mold is connected to the actuator of an Instron 8521 servohydraulic
system (F) and cyclically loaded via an aluminum rod (G). The SBF
level and maximum and minimum positions that the Delrin1 mold is
displaced to are labeled on the figure. Holes in the Delrin1 mold
that did not have a PLGA scaffold were plugged with rubber stop-
pers. 1 L of SBF solution is housed in the aluminum base during
mineralization. The Delrin1 mold can simultaneously cast sixteen
10–mm diameter scaffolds (or twenty-five 5-mm diameter scaffolds,
not shown).
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hood. Scaffolds were scanned (n ¼ 4 for 5-day mineralized
scaffolds, n ¼ 8 for 3-day coprecipitated mineralized scaf-
folds) in a MicroCT system (EVS MS8X-130, 16-mm voxel
size) to obtain MV% and 3D rendered images (Micro-
View1, GE Systems). MicroCT scans were obtained at 75
mA and 75 mV for 400 frames using an aluminum filter.
All reconstructed images were rendered in MicroView1
using the Isosurface tool at a threshold of 1000 with the
smoothing filter on, and at a surface quality factor of 0.55.
A MV% profile for each group (filtration, submerged con-
trol, and floating control) was calculated using a volumetric
shrinkage program written in MATLAB. This program cal-
culates the centroid of each scaffold from a user-defined
region of interest volume in MicroView, and subsequently
uses spline calculations to determine a 16.7% volume
shrinkage from the original volume. Analysis of progres-
sively smaller concentric volumes resulted in six different
shells of equal volumes per scaffold. The term ‘‘innermost
shell’’ refers to the innermost volume, which is cylindrical
in shape. The other five volumes calculated were concentric
cylindrical shells. The MV% was calculated for each shell
to compare the mineral gradient within and between the
scaffold groups.
XRD Analysis
XRD spectra were obtained using a Rigaku Miniflex X-ray
diffractometer with a fixed incidence of 4.28. A range of
10–908 was scanned using a step size of 0.18 and a scan
rate of 18/min. The top surface of all of the scaffolds was
scanned, unless otherwise noted. The raw data of a repre-
sentative sample were plotted for all groups to compare the
different conditions, which included filtration 5 days (n ¼
2), filtration 3 days (n ¼ 1), filtration 1 day (n ¼ 1), sub-
merged control (5 days, n ¼ 2), and filtration control (5
days, n ¼ 2). The filtration samples retrieved after 1, 3,
and 5 days were analyzed to evaluate time-dependent
changes in mineral. A blank PLGA scaffold was also
scanned to detect background from the substrate material.
To investigate if the mineral formed in the center of the fil-
tration scaffolds was similar to the mineral formed on the
surface, 5-day filtration scaffolds were transversely cut and
analyzed (filtration center 5 days, n ¼ 2). Hydroxyapatite
(Sigma-Aldrich #289396) and 6 wt % carbonated apatite
(generous gift from Dr. Mike Morris, University of Michi-
gan) were scanned as standards.
FTIR Analysis
Characteristic peaks for apatite were detected using a Fou-
rier Transform Infrared Spectrometer (Spectrum BX FTIR,
Perkin Elmer). A 300:1 ratio of KBr to deposited mineral
was used prepare a pellet and analyze the filtration, sub-
merged control, and filtration control groups (n ¼ 2). Spec-
tra were recorded from 400 to 4000 cm1 and baseline
corrected.
BSA Quantification
The amount of BSA coprecipitated onto the scaffolds (n ¼
8) was detected using a UV spectrophotometer (SmartSpec
3000, BioRad). Each scaffold was demineralized in 10 mM
HCl. An aliquot of the demineralization solution was meas-
ured at a wavelength of 494 nm to detect the FITC conju-
gated to the BSA. Concentrations of coprecipitated FITC–
BSA were determined from a standard curve prepared with
a 1:5 ratio of FITC–BSA to BSA. The calibration curve
was constructed for the FITC–BSA:BSA solution using se-
rial dilutions in 13 PBS. Protein densities were calculated
using values for the amount of mineral precipitated from
MicroCT analyses and the amount of BSA coprecipitated
from the quantitative UV spectrophotometry.
Confocal Microscopy
A 1–2-mm thick center cross-section from protein incorpo-
rated scaffolds was cut to expose the 2-mm depth of the
scaffolds (n ¼ 4). Each section, rectangular in shape (10
mm 3 2 mm 3 1–2 mm), was sandwiched between a glass
slide and glued cover slip and viewed using confocal mi-
croscopy (Nikon TE 3000 Inverted Microscope) at an exci-
tation wavelength of 488 nm. A BioRad Radiance 2000
LaserSharp program was used to image 750 mm into the 1–
2-mm section at 3-mm intervals under 103 magnification.
The series of images was compiled in the LaserSharp pro-
gram to yield images showing FITC–BSA incorporation
throughout the 750 mm. Multiple images were obtained
across each sample and were mosaic-tiled together. The
center cross-sections from scaffolds mineralized via filtra-
tion (5-day mineralization using the previously described
43 SBF/23 SBF regimen) without fluorescent-labeled pro-
tein were also investigated to characterize any mineral
autofluorescence.
Statistics
The effect of filtration on MV% was determined using a
one-way analysis of variance (ANOVA) on ranks with Stu-
dent–Newman–Keuls post hoc evaluation. Significant dif-
ferences in MV% between the concentric volumes within
each group were also determined using ANOVA on ranks.
The effects of filtration on MV% and on FITC–BSA incor-
poration for the BSA scaffolds were determined using a
Student’s t-test. Significance was defined as p < 0.05, and
all statistics were calculated using SigmaStat v3.1.
RESULTS
Uniform, Continuous Mineral Precipitated Throughout
the Depth of Filtered Scaffolds
Filtration of SBF through the scaffold pores significantly
increased the mineral deposition compared to both the sub-
merged and floating static control groups (Figures 2 and 3).
The qualitative 3D MicroCT renderings for the filtration
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and submerged control groups show increased mineral
within the filtration group (Figure 2). The cross-section
images [Figure 2(c,f)] also confirmed that mineral was
present throughout the thickness of the filtration scaffolds.
The floating control group 3D renderings did not show any
mineralization (images not shown). The MV% in the filtra-
tion scaffolds was significantly greater than both control
groups (floating control p ¼ 0.029, submerged control p ¼
0.029). There was also an even distribution of mineral
throughout the filtration scaffolds compared with both con-
trol groups, which had >60% of the precipitated mineral in
the two outermost shell volumes (Figure 4). If the average
amount of mineral precipitated (8%, Figure 3) on the fil-
tration scaffolds is combined with the initial amount of
PLGA present (5%), the scaffold porosity would decrease,
on average, from 95% to approximately 87% for the filtra-
tion scaffolds.
The mineral deposited on the scaffolds showed charac-
teristic FITR peaks for both hydroxyapatite (m3c PO 1032
cm1, m1 PO 962 cm
1, m4a OPO 602 cm
1, and
m4c OPO 561 cm
1 [filtration group only]) and carbonated
apatite (m1CO23 1465 cm
1 [filtration and floating control
groups])30 (Figure 5). XRD spectra for all of the groups
also show apatite characteristic 2y peaks between 25.98 and
26.88, between 31.88 and 32.78, at 40.18, and between 458
and 558 (Figure 6).30 The XRD spectra further reveal that
the peaks from the filtration scaffolds are consistent over
the 5 days of mineralization, providing evidence that the
mineral being precipitated on days 1 and 3 is similar to the
mineral being precipitated on day 5. Last, XRD analysis
confirms that the type of mineral deposited was similar in
Figure 2. Representative MicroCT images of the filtration group (a–
c) and the submerged control group (d–f). These images represent
top (a,d), side (b,e), and center cross-sections (c,f). A greater
amount of mineral formed on the filtration scaffolds in comparison
to the submerged control group. Renderings of the floating control
group are not shown because mineral present in the images was
minimal (<0.2 MV%). All images were created in MicroView1 using
the Isosurface tool (voxel size = 16 mm, threshold = 1000, surface
quality factor = 0.55).
Figure 3. MV% for the filtration, floating control, and submerged
control groups demonstrated the filtration group mineralized the
greatest amount. (*p = 0.029 vs. both controls). MV% was calcu-
lated from MicroCT data using MicroView1 at a threshold of 1000.
Figure 4. Volumetric mineral analysis of the MicroCT images
(threshold = 1000) showing the filtration scaffolds have a uniform
mineral profile throughout all six regions of the scaffolds analyzed.
The MV% for 6 concentric shell volumes show the control mineral-
ized scaffolds have at minimum 60% of the mineral present in the 2
outer shells (shells 1 and 2). The floating control group shell vol-
umes were statistically different from one another (n = 4, p = 0.002),
whereas the submerged control and filtration groups did not show
significance (n = 3, p = 0.051 and n = 4, p = 0.104, respectively).
*Statistical significance found, p < 0.050.
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all three experimental groups (filtration, submerged control,
and floating control).
Uniform and Increased BSA Incorporation in
Filtered Scaffolds
A 10-fold increase in protein incorporation (Figure 7) was
established in the scaffolds mineralized using the filtration
device. Confocal microscopy supported the increased pro-
tein incorporation within the filtration group, in addition to
showing uniform precipitation throughout the thickness of
the scaffolds (Figure 8). The confocal microscopy methods
followed in these [Figure 8(c)] and other experiments
revealed no interfering autofluorescence from the PLGA or
the mineral.19 Similar to the 5-day filtration mineralized
scaffolds, a greater amount of mineral was deposited on the
3-day coprecipitated filtration scaffolds compared to the
static controls, p < 0.001 (Figure 9).
DISCUSSION
Using the filtration system developed, a uniform 3D sub-
strate surface that mimics the inorganic composition of
bone was created, providing a microenvironment that could
potentially enhance osteogenesis.31 Designing a biomaterial
that can enhance the ability of cells to attach and prolifer-
ate is an imperative aspect of controlling cellular microen-
vironment. Seeding cells on 3D scaffolding as a first step
in controlling cell function however, is not trivial.32 Non-
uniform apatite coverage on scaffolding is preventative of
uniform cell seeding. By establishing a technique that can
consistently provide uniform and continuous mineral cover-
age of 3D porous scaffolding, it is hypothesized that cell
seeding uniformity will be enhanced and uniform osteogen-
esis will be more likely to occur.
The precipitation of a continuous mineral film onto pore
surfaces of the polymer substrate was the goal of the initial
filtration experiment. Appropriate ion concentrations are
necessary for calcium phosphate growth,33 particularly
within the internal pores of a 3D scaffold. In order to main-
tain film formation, the thermodynamics of the SBF must
be held below the homogenous precipitation limit and
above the solute saturation limit.34 If these conditions are
not met, then no or minimal mineral will form.20,34 To pro-
vide the pore surfaces within the interstices of the scaffolds
appropriate ion concentrations for film formation to occur, the
Figure 5. FTIR spectra for filtration, floating control, and submerged
control groups showing the mineral deposited on the scaffolds was
characteristic of hydroxyapatite with carbonate peaks (m3c PO 1032
cm1, m1 PO 962 cm
1, m4a OPO 602 cm
1, and m4c OPO 561
cm1 [filtration group only]) and carbonated apatite (m1CO23 1465
cm1 [filtration and floating control groups]). Stronger peaks for the
filtration group indicate the presence of moremineral.
Figure 6. XRD spectra for all three groups (filtration, floating con-
trol, submerged control) show characteristic apatite peaks between
25.98 and 26.88, between 31.88 and 32.78, at 40.18, and between
458 and 558 when compared to the hydroxyapatite standard. A simi-
lar type of mineral was precipitated over the 5 days of filtration (1,
3, and 5 days). To assess if the mineral formed within the center of
the filtration scaffolds was similar to the mineral formed on the sur-
face of the filtration scaffolds, 5-day scaffolds were sectioned trans-
versely and analyzed (filtration center 5 days). The mineral formed
on the interior surface of 5-day filtration scaffolds showed a similar
spectrum to the mineral formed on the outer surface of the same
scaffolds at 5 days, verifying that a similar mineral formed through-
out the depth of the scaffold.
Figure 7. Quantitative coprecipitated BSA values (mg) showing
greater protein incorporation in the filtered scaffolds. The amount of
BSA incorporated was quantified using UV Spectrophotometry at
494nm wavelength to detect the FITC–BSA. (*Statistically significant
compared to submerged control group, p < 0.001).
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delivery method of SBF can be enhanced. Flow perfusion bio-
reactors have already shown that increased mass transfer in
3D is responsible for increases in cell numbers, resulting in
uniform tissue growth.35 Additionally, the flow conditions
and resulting shear stresses that occur within these bioreactors
have been modeled.36 By facilitating flow of the SBF through
the scaffold pores, an appropriate ion concentration was
expected to occur within the interstices of the scaffolds allow-
ing mineral to form throughout the thickness.
To further accelerate mineral nucleation on all pore sur-
faces, the PLGA polymer surface was treated with NaOH,
facilitating alkaline hydrolysis that increases the number of
free carboxylic acid groups on the surface. This treatment
accelerates heterogeneous precipitation of a bone-like min-
eral by creating an environment where free carboxylic acid
groups that can interact with ions in solution are formed at
a greater rate than just by hydrolysis in SBF.20 The pres-
ence of negatively charged surface groups provides a sub-
strate more capable of apatite nucleation compared to
positively charged surfaces.37
The enhancements to the SBF delivery and more rapid
functionalization of the polymer surface together indicate
that an appropriate ion concentration was established within
the filtration scaffolds. While both control scaffold groups
were treated with NaOH, neither group showed continuous
mineralization through the scaffold thickness, showing that
the improvement to SBF delivery via flow is responsible
for the continuous mineralization seen within the filtration
scaffolds. Maintaining this appropriate ionic environment
depends on temperature, pH, and the concentration of the
solutes. Efforts to control the temperature and pH were
enforced by the use of a temperature controller held at 37
6 18C and frequent replacement of the SBF solution. The
pH values of both the new and used SBF were monitored
every time the SBF was changed (every 6 h for 43 SBF
and every 12 h for 23 SBF), and the filtration group had
an average increase in pH of 0.47 6 0.09, whereas the sub-
merged group had an average increase of 0.37 6 0.07. The
pH changes reported are the maximum values that the pH
had increased over a 12-h period and are likely to occur
for a small percentage of each incubation period, because
the SBF is replenished in a timely fashion. These pH
changes keep the pH value of the solution between 6.4 and
6.8 when the scaffolds are submerged in 43 SBF and
between 6.8 and 7.2 when the scaffolds are submerged in
23 SBF. The pH changes that occurred are thought to be
greater than pH changes resulting solely from ion deple-
tion, because the SBF in all groups is not completely
sealed from the atmosphere nor titrated to maintain a con-
stant pH.
Despite fluctuations in pH, the mineral precipitated in
the filtration, submerged control, and floating control
groups all show characteristic XRD peaks of carbonated
apatite. The mineral formed at 1, 3, and 5 days using the
filtration system is similar (Figure 6). The 1-day filtration
spectrum had the lowest intensity above the background,
suggesting that the mineral could be less crystalline than
the mineral formed at later times. This indicates that a
more amorphous apatite phase or a nanocrystalline phase
could be forming during the first day of precipitation. This
Figure 9. MV% for the filtration and submerged control coprecipita-
tion groups demonstrated the filtration group mineralized the great-
est amount (*p < 0.001). MV% was calculated from MicroCT data
using MicroView1 at a threshold of 1000.
Figure 8. Representative confocal microscopy images of transverse
sections of filtration (a) and submerged control (b) groups coprecipi-
tated with BSA for 3 days. The mosaic images were compiled from
multiple images of the center cross-section for each scaffold in
each group (n = 4 per group). The incorporation of BSA is shown by
the fluorescence of FITC conjugated to the BSA. The filtration scaf-
folds showed uniform BSA coprecipitation throughout. A typical
mineral shell, evidenced by more FITC seen on the left and right
edges, is seen for the submerged control group. The presence of a
mineral shell also supports less BSA incorporation. Autofluores-
cence of the mineral was not detected, shown by a representative
image of a center cross-section of a scaffold mineralized via filtra-
tion for 5 days using the 43 SBF/23 SBF regimen precipitated
without protein (c). Original images were taken at 103. [Color figure
can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
346 SEGVICH ET AL.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
DOI 10.1002/jbmb
XRD spectrum after 1 day of mineralization is consistent
with spectra of apatite precipitated on PLLA and PGA
films after 24 h in a 53 SBF solution.38 Spatially, the min-
eral precipitated on the outer scaffold surface (filtration 5
days) showed similar peaks as the mineral precipitated
within the center of the scaffold (filtration center 5 days),
supporting the deposition of uniform mineral throughout
the filtration scaffolds. Because most forms of calcium
phosphate that differ by a few percent in carbonate substi-
tution have overlapping peaks, it is difficult to discern the
specific type of apatite or calcium phosphate being formed
in these experiments from the XRD spectra. However, car-
bonated apatite characteristic peaks were detected for the
filtration and floating control groups in FTIR analysis, pro-
viding evidence that a carbonated apatite is being precipi-
tated onto the scaffolds. The decreased resolution of the
precipitated bone-like apatite compared to the hydroxyapa-
tite and carbonated apatite standards could result from ei-
ther the precipitated mineral being crystalline but having
nanometer-range crystal size or the precipitated mineral
containing a large fraction of an amorphous phase.39 A
slight peak shift to higher 2y values was seen for the sub-
merged control and filtration (3 days) samples compared to
the rest of the samples, which could be indicative of chlo-
ride substitutions within the apatite being formed.30
A model protein, BSA, was successfully incorporated
into the mineral layer within 3 days. A 10-fold increase of
protein incorporation was found in the coprecipitated scaf-
folds via filtration compared to the submerged control scaf-
folds (Figure 7). More protein incorporation in the filtration
coprecipitation group is attributed to increased mineral for-
mation on these scaffolds (Figure 8). The amount of pro-
tein coprecipitated within the filtration and submerged
control groups (1308 6 464 and 139 6 45 mg, respec-
tively) are comparable to previous coprecipitation reports
that incorporated biomolecules within mineral or polymeric
materials.19,40,41 Additionally, the scaffolds coprecipitated
via filtration displayed uniform protein incorporation
throughout the scaffold thickness, whereas the scaffolds
coprecipitated via submersion showed protein incorporation
only on the outer surfaces (Figure 9). This uniform incor-
poration would allow uniform biomolecular release
throughout the scaffold in an in vitro or in vivo setting.
The protein densities for the filtration and submerged
control groups were 345 6 164 and 1260 6 410 mg/mm3,
respectively. The increased density within the submerged
control is likely attributed to a static mineralization that
allowed the BSA to adsorb to the surface of the scaffold
prior to mineralization, whereas in the filtration group fluid
movement limited BSA adsorption. However, cells trans-
planted onto coprecipitated scaffolds could favor a lower
protein loading density. Coprecipitated inorganic coatings
have shown to be effective on a dense 3D materials,26,42,43
and spatial control of the organic constituents within the
coating of a film has been achieved19; however, to our
knowledge, this is the first investigation of coprecipitation
of mineral with protein on a 3D porous template. The aim
of using the filtration method is to spatially localize biomo-
lecules that promote bone formation into a more effective
bone engineered template.
When coating implant materials, such as titanium hip
replacements, the 2D surface is coated with a thick mineral
layer to ensure the coating is present on the implant after
the surgery. However, the design strategy of coating the
pores of a 3D scaffold for tissue engineering differs from
coating a 2D surface, because a main objective of coating
a 3D scaffold is to retain porosity. Therefore, current coat-
ing techniques would not be effective in uniformly coating
all pore surfaces within a 3D scaffold with a thin mineral
layer, demonstrating the need for a method to uniformly
coat pore surfaces of 3D scaffolds without compromising
porosity.
Techniques to precipitate a uniform, continuous calcium
phosphate layer on porous polymer scaffolds via preminer-
alization aminolysis or hydrolysis have not been able to es-
tablish a continuous mineral layer in a time effective
manner. Even with longer precipitation times, the mineral
layer is not continuous throughout the thickness. The result
is a thicker layer of mineral around the periphery of the
scaffold, which can lead to pore occlusion and compromise
cell function. An increase in the volume fraction of regen-
erated bone occurs on statically mineralized PLGA scaf-
folds having a 250–425 mm pore size range, compared to
PLGA controls.31 In the presented work, the scaffold pore
size ranged from 425 to 600 mm, so, as an example, a 20-
mm thick layer of mineral would decrease the pore size
range to 405–580 mm, which is larger than the pore size
reported by Kohn et al. but within an identified range for
bone ingrowth.44 Ultimately, the presence of continuous
bone-like mineral throughout the polymer scaffolds is
expected to lead to more continuous in vivo osteogenesis.
Although the initial design of the system enables a batch
of sixteen 10-mm diameter scaffolds, mineralization of
twenty-five 5-mm diameter scaffolds has also proved feasi-
ble (data not shown). Moreover, this system is not limited
to PLGA scaffolds. Any material capable of being con-
strained in the Delrin1 mold can be used with scaffold di-
ameter and thickness as variable parameters.
In summary, incorporating a bone-like apatite mineral
layer on polymer scaffolds in an environment conducive to
biomolecular incorporation has the potential to increase the
ability of cell recognition, attachment, and regeneration in
vivo. A filtration device designed to force SBF through the
pores of scaffolds enabled a uniform, continuous bone-like
mineral layer to form throughout, and uniform mineral cov-
erage could be attained in only 4–5 days. Additionally, a
model protein, BSA, was coprecipitated uniformly in the
bone-like mineral layer throughout the thickness of the
scaffolds. Scaffolds mineralized within the filtration device
displayed an increase in MV% and in the amount of incor-
porated BSA via coprecipitation compared to static miner-
alization. This filtration system can potentially be used to
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incorporate cell-signaling biomolecules, such as growth fac-
tors or DNA, to promote in vivo osteogenesis, in addition
to serving as a technology to develop conductive materials.
The authors would like to thank the University of Michigan
Chemistry Machine Shop and the Orthopedic Research Lab
Machine Shop for their craftsmanship, in addition to Dr. Scott
Hollister for the generous use of the MicroCT. The authors would
also like to thank Jeff Meganck for his MATLAB expertise, Ricky
Rossello, Colleen Flanagan, and Mike Barker for their helpful
advice.
REFERENCES
1. Wiesmann HP, Joos U, Meyer U. Biological and biophysical
principles in extracorporal bone tissue engineering. Part II. Int
J Oral Maxillofac Surg 2004;33:523–530.
2. Parikh SN. Bone graft substitutes in modern orthopedics.
Orthopedics 2002;25:1301–1309; 1310–1311.
3. Muschler GF, Midura RJ. Connective tissue progenitors: prac-
tical concepts for clinical applications. Clin Orthop Relat Res
2002;395:66–80.
4. Feinberg SE, Aghaloo TL, Cunningham LL Jr. Role of tissue
engineering in oral and maxillofacial reconstruction: Findings
of the 2005 AAOMS Research Summit. J Oral Maxillofac
Surg 2005;63:1418–1425.
5. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG.
Evolution of bone transplantation: molecular, cellular and tis-
sue strategies to engineer human bone. Biomaterials 1996;
17:175–185.
6. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue en-
gineering. Biomaterials 2003;24:4353–4364.
7. Garcia AJ, Reyes CD. Bio-adhesive surfaces to promote
osteoblast differentiation and bone formation. J Dent Res
2005;84:407–413.
8. Maskarinec SA, Tirrell DA. Protein engineering approaches to
biomaterials design. Curr Opin Biotechnol 2005;16:422–426.
9. Hubbell JA. Bioactive biomaterials. Curr Opin Biotechnol
1999;10:123–129.
10. Alsberg E, Hill EE, Mooney DJ. Craniofacial tissue engineer-
ing. Crit Rev Oral Biol Med 2001;12:64–75.
11. Hirano Y, Mooney DJ. Peptide and protein presenting materi-
als for tissue engineering. Adv Mater 2004;16:17–25.
12. Chen RR, Mooney DJ. Polymeric growth factor delivery strat-
egies for tissue engineering. Pharm Res 2003;20:1103–1112.
13. Rose FRAJ, Oreffo ROC. Bone tissue engineering: Hope vs
hype. Biochem Biophys Res Commun 2002;292:1–7.
14. Ogino M, Ohuchi F, Hench LL. Compositional dependence
of the formation of calcium phosphate films on bioglass.
J Biomed Mater Res 1980;14:55–64.
15. Abe Y, Kokubo T, Yamamuro T. Apatite coating on
ceramics, metals and polymers utilizing a biological process.
J Mater Sci Mater Med 1990;1:233–238.
16. de Groot K, Wolke JG, Jansen JA. Calcium phosphate coat-
ings for medical implants. Proc Inst Mech Eng [H]
1998;212:137–147.
17. Habibovic P, Barrere F, van Blitterswijk CA, de Groot K,
Layrolle P. Biomimetic hydroxyapatite coating on metal
implants. J Am Ceram Soc 2002;85:517–522.
18. Murphy WL, Kohn DH, Mooney DJ. Growth of continuous
bonelike mineral within porous poly(lactide-co-glycolide)
scaffolds in vitro. J Biomed Mater Res 2000;50:50–58.
19. Luong LN, Hong SI, Patel RJ, Outslay ME, Kohn DH. Spatial
control of protein within biomimetically nucleated mineral.
Biomaterials 2006;27:1175–1186.
20. Murphy WL, Mooney DJ. Bioinspired growth of crystalline
carbonate apatite on biodegradable polymer substrata. J Am
Chem Soc 2002;124:1910–1917.
21. Croll TI, O’Connor AJ, Stevens GW, Cooper-White JJ.
Controllable surface modification of poly(lactic-co-glycolic
acid) (PLGA) by hydrolysis or aminolysis I: Physical, chemi-
cal, and theoretical aspects. Biomacromolecules 2004;5:463–
473.
22. Zhang R, Ma PX, Biomimetic polymer/apatite composite
scaffolds for mineralized tissue engineering. Macromol Biosci
2004;4:100–111.
23. Oliveira AL, Malafaya PB, Reis RL. Sodium silicate gel as a
precursor for the in vitro nucleation and growth of a bone-
like apatite coating in compact and porous polymeric struc-
tures. Biomaterials 2003;24:2575–2584.
24. Wen HB, de Wijn JR, van Blitterswijk CA, de Groot K.
Incorporation of bovine serum albumin in calcium phos-
phate coating on titanium. J Biomed Mater Res 1999;46:
245–252.
25. Wen HB, Wolke JG, de Wijn JR, Liu Q, Cui FZ, de Groot K.
Fast precipitation of calcium phosphate layers on titanium
induced by simple chemical treatments. Biomaterials 1997;
18:1471–1478.
26. Liu Y, Hunziker EB, Layrolle P, De Bruijn JD, de Groot K.
Bone morphogenetic protein 2 incorporated into biomimetic
coatings retains its biological activity. Tissue Eng 2004;10:
101–108.
27. Azevedo HS, Leonor IB, Alves CM, Reis RL. Incorporation
of proteins and enzymes at different stages of the preparation
of calcium phosphate coatings on a degradable substrate by a
biomimetic methodology. Mater Sci Eng C Biomimetic
Supramol Syst 2005;25:169–179.
28. Liu Y, Layrolle P, de Bruijn J, van Blitterswijk C, de Groot
K. Biomimetic coprecipitation of calcium phosphate and bo-
vine serum albumin on titanium alloy. J Biomed Mater Res
2001;57:327–335.
29. Kokubo T. Apatite formation on organic polymers by a bio-
mimetic process. Eur J Solid State Inorg Chem 1995;32:819–
827.
30. Koutsopoulos S. Synthesis and characterization of hydroxyap-
atite crystals: A review study on the analytical methods.
J Biomed Mater Res 2002;62:600–612.
31. Kohn DH, Shin K, Hong SI, Jayasuriya AC, Leonova EV,
Rossello RA, Krebsbach PH. Self-assembled mineral scaffolds
as model systems for biomineralization and tissue engineer-
ing. Proceedings of the Eight International Conference on
the Chemistry and Biology of Mineralized Tissues, 2005. pp.
216–219.
32. Toh YC, Ho ST, Zhou Y, Hutmacher DW, Yu H. Application
of a polyelectrolyte complex coacervation method to improve
seeding efficiency of bone marrow stromal cells in a 3D cul-
ture system. Biomaterials 2005;26:4149–4160.
33. Feng QL, Cui FZ, Wang H, Kim TN, Kim JO. Influence of
solution conditions on deposition of calcium phosphate on ti-
tanium by NaOH-treatment. J Cryst Growth 2000;210:735–
740.
34. Bunker BC, Rieke PC, Tarasevich BJ, Campbell AA, Fryxell
GE, Graff GL, Song L, Liu J, Virden JW, McVay GL. Ceramic
thin-film formation on functionalized interfaces through bio-
mimetic processing. Science 1994;264:48–55.
35. Bancroft GN, Sikavitsas VI, Mikos AG. Design of a flow per-
fusion bioreactor system for bone tissue-engineering applica-
tions. Tissue Eng 2003;9:549–554.
36. Porter B, Zauel R, Stockman H, Guldberg R, Fyhrie D. 3-D
computational modeling of media flow through scaffolds in a
perfusion bioreactor. J Biomech 2005;38:543–549.
37. Tanahashi M, Matsuda T. Surface functional group depend-
ence on apatite formation on self-assembled monolayers in
348 SEGVICH ET AL.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
DOI 10.1002/jbmb
a simulated body fluid. J Biomed Mater Res 1997;34:305–
315.
38. Chen Y, Mak AF, Li J, WangM, Shum AW. Formation of apatite
on poly(alpha-hydroxy acid) in an accelerated biomimetic pro-
cess. J BiomedMater Res BAppl Biomater 2005; 73:68–76.
39. Posner AS, Blumenthal NC, Betta F. Chemistry and structure
of hydroxyapatites. In: Nriagu JO, Moore PB, editors. Phos-
phate Minerals. Berlin: Springer Verlag; 1984. p. 330.
40. Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery
from polymer matrices for tissue engineering. Nat Biotechnol
1999;17:551–554.
41. Kim H, Kim HW, Suh H. Sustained release of ascorbate-2-
phosphate and dexamethasone from porous PLGA scaffolds
for bone tissue engineering using mesenchymal stem cells.
Biomaterials 2003;24:4671–4679.
42. Liu Y, de Groot K, Hunziker EB. BMP-2 liberated from bio-
mimetic implant coatings induces and sustains direct ossifica-
tion in an ectopic rat model. Bone 2005;36:745–757.
43. Stigter M, de Groot K, Layrolle P. Incorporation of tobramy-
cin into biomimetic hydroxyapatite coating on titanium. Bio-
materials 2002;23:4143–4153.
44. Hollister SJ, Lin CY, Saito E, Lin CY, Schek RD, Taboas
JM, Williams JM, Partee B, Flanagan CL, Diggs A, Wilke
EN, Van Lenthe GH, Müller R, Wirtz T, Das S, Feinburg SE,
Krebsbach PH. Engineering craniofacial scaffolds. Orthod
Craniofac Res 2005;8:162–173.
349UNIFORM DEPOSITION OF PROTEIN–MINERAL COATING ON 3D SCAFFOLDS
Journal of Biomedical Materials Research Part B: Applied Biomaterials
DOI 10.1002/jbmb
